Characteristics of state prescription drug monitoring programs: a state-by-state survey.

摘要: OBJECTIVES: Prescription drug monitoring programs (PDMPs) are state-based data collection systems recording controlled substance medications. Currently, 49 states have PDMPs. There discrepancies in reporting patterns, infrastructure, and oversight between programs. We characterized aspects of each state's PDMP. METHODS: A web search PDMP was conducted, a list all administrators obtained. From August 1 to November 31, 2014, link web-based survey sent administrator. Closed-ended questions included type access, mandatory-use programs, sharing, proactive contact with patients or health care providers, details pharmacy reporting, protocols for identifying "high-risk" patients. Descriptive statistics were used analysis. RESULTS: received 100% response rate (49/49). Ninety-six percent (47/49) physician-accessible Most, 68% (32/49), do not an enrollment mandate physicians. Prior prescribing medications, 16% (8/49) require prescribers access their More than half (53%, 26/49) reported patient prescriptions over the past two more years. 57% (28/59), lag time week longer appear database after prescription filling. majority (65% 32/49) share at least one other state. Protocols exist identify high-risk misuse 55% (27/49) states. CONCLUSION: Characteristics PDMPs heterogeneous throughout country. Standardizing capture, availability, would improve usefulness providers. Copyright © 2016 John Wiley & Sons, Ltd.Copyright Ltd. Language: en